Adverum Revenue Per Employee vs Average Equity Analysis
ADVM Stock | USD 10.19 0.81 7.36% |
Trend analysis of Adverum Biotechnologies balance sheet accounts such as Short Long Term Debt Total of 63.9 M, Other Current Liabilities of 13.1 M or Total Current Liabilities of 15 M provides information on Adverum Biotechnologies' total assets, liabilities, and equity, which is the actual value of Adverum Biotechnologies to its prevalent stockholders. By breaking down trends over time using Adverum Biotechnologies balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Adverum |
About Adverum Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Adverum Biotechnologies at a specified time, usually calculated after every quarter, six months, or one year. Adverum Biotechnologies Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Adverum Biotechnologies and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Adverum currently owns. An asset can also be divided into two categories, current and non-current.
Adverum Biotechnologies Balance Sheet Chart
Adverum Biotechnologies Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Adverum Biotechnologies uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Adverum Biotechnologies' Liabilities And Stockholders Equity is very stable compared to the past year. As of the 25th of April 2024, Non Current Liabilities Total is likely to grow to about 67.9 M, while Total Current Liabilities is likely to drop about 15 M. Add Fundamental
Total Assets
Total assets refers to the total amount of Adverum Biotechnologies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Adverum Biotechnologies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Adverum Biotechnologies balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Adverum Biotechnologies are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Adverum Biotechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adverum Biotechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.As of the 25th of April 2024, Sales General And Administrative To Revenue is likely to grow to 17.94, while Selling General Administrative is likely to drop about 31.8 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 153.6M | 157.1M | 121.7M | 81.4M | Cost Of Revenue | 4.6M | 6.5M | 5.6M | 5.4M |
Adverum Biotechnologies fundamental ratios Correlations
Click cells to compare fundamentals
Adverum Biotechnologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Adverum Biotechnologies fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 222.7M | 482.6M | 439.7M | 308.4M | 173.0M | 247.9M | |
Other Current Liab | 2.6M | 1.3M | 2.0M | 16.8M | 12.5M | 13.1M | |
Total Current Liabilities | 19.4M | 20.9M | 21.3M | 32.2M | 24.9M | 15.0M | |
Total Stockholder Equity | 175.0M | 434.3M | 316.2M | 181.5M | 83.5M | 79.3M | |
Other Liab | 1.4M | 48K | 1.1M | 1.0M | 942.3K | 895.2K | |
Property Plant And Equipment Net | 45.8M | 47.1M | 119.1M | 113.9M | 67.0M | 37.4M | |
Net Debt | (33.6M) | (31.7M) | 68.8M | 38.4M | 36K | 37.8K | |
Retained Earnings | (385.0M) | (502.5M) | (648.1M) | (802.6M) | (919.8M) | (873.8M) | |
Accounts Payable | 4.1M | 2.8M | 1.4M | 2.2M | 1.9M | 1.9M | |
Cash | 65.9M | 62.4M | 34.2M | 68.4M | 75M | 78.2M | |
Non Current Assets Total | 46.9M | 48.1M | 122.6M | 117.8M | 70.2M | 39.7M | |
Cash And Short Term Investments | 166.0M | 429.7M | 305.2M | 185.6M | 96.5M | 91.7M | |
Common Stock Shares Outstanding | 6.4M | 8.5M | 9.8M | 9.9M | 10.1M | 18.4M | |
Liabilities And Stockholders Equity | 222.7M | 482.6M | 439.7M | 308.4M | 173.0M | 247.9M | |
Non Current Liabilities Total | 28.4M | 27.3M | 102.2M | 94.6M | 64.6M | 67.9M | |
Other Current Assets | 9.8M | 4.7M | 6.2M | 5.0M | 6.2M | 4.0M | |
Other Stockholder Equity | 560.7M | 937.1M | 965.0M | 985.7M | 1.0B | 567.3M | |
Total Liab | 47.8M | 48.2M | 123.5M | 126.9M | 89.5M | 46.9M | |
Property Plant And Equipment Gross | 24.9M | 47.1M | 132.2M | 130.9M | 81.5M | 85.6M | |
Total Current Assets | 175.9M | 434.4M | 317.1M | 190.6M | 102.8M | 97.6M | |
Accumulated Other Comprehensive Income | (725K) | (261K) | (714K) | (1.5M) | (473K) | (496.7K) | |
Property Plant Equipment | 24.9M | 27.7M | 33.1M | 113.9M | 130.9M | 137.5M | |
Non Currrent Assets Other | 11K | 29K | 250K | 1.4M | 1.2M | 1.3M | |
Other Assets | 1.0M | 1.0M | 3.5M | 3.9M | 4.5M | 4.7M | |
Net Tangible Assets | 175.0M | 434.3M | 316.2M | 181.5M | 208.7M | 256.7M | |
Common Stock Total Equity | 5K | 6K | 7K | 10K | 11.5K | 6.5K | |
Retained Earnings Total Equity | (320.5M) | (385.0M) | (502.5M) | (648.1M) | (583.3M) | (554.1M) | |
Short Term Investments | 100.1M | 367.3M | 271.0M | 117.2M | 21.5M | 20.4M | |
Capital Surpluse | 522.5M | 560.7M | 937.1M | 965.0M | 1.1B | 599.6M | |
Short Term Debt | 4.0M | 4.5M | 1.9M | 13.2M | 10.4M | 6.1M | |
Common Stock | 5K | 6K | 7K | 10K | 11.5K | 7.4K | |
Non Current Liabilities Other | 28.4M | 27.3M | 102.2M | 1.0M | 1.2M | 1.1M | |
Net Invested Capital | 175.0M | 434.3M | 316.2M | 181.5M | 83.5M | 79.3M | |
Net Working Capital | 156.5M | 413.6M | 295.8M | 158.3M | 77.9M | 74.0M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adverum Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adverum Biotechnologies' short interest history, or implied volatility extrapolated from Adverum Biotechnologies options trading.
Pair Trading with Adverum Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adverum Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving against Adverum Stock
0.55 | CGC | Canopy Growth Corp Trending | PairCorr |
0.54 | ACB | Aurora Cannabis Trending | PairCorr |
0.44 | ELYM | Eliem Therapeutics | PairCorr |
The ability to find closely correlated positions to Adverum Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adverum Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adverum Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adverum Biotechnologies to buy it.
The correlation of Adverum Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adverum Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adverum Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adverum Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Adverum Stock analysis
When running Adverum Biotechnologies' price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.60) | Revenue Per Share 0.357 | Quarterly Revenue Growth (0.70) | Return On Assets (0.32) | Return On Equity (0.88) |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.